MedArbor Diagnostics

CLEVELAND, Dec. 6, 2024 /PRNewswire/ -- Wildcat DX, LLC is thrilled to announce its acquisition of Navis Clinical Laboratories, Inc., a leading provider of diagnostic lab testing services. Navis has long been dedicated to excellence, innovation, and delivering exceptional value to its clients. The new ownership group shares these core values, and their involvement will further enhance our ability to expand and improve our products and services. As part of this transition, Dr. Damon Borg has been appointed as interim CEO. Navis is an exciting addition to the already impressive portfolio of Health Care companies owned and operated by the Wildcat DX, LLC management team. Some of the companies in this portfolio include; "We are extremely excited to add and synergize Navis into our expanding health care network. Navis has a long-standing reputation of being one of the top toxicology laboratories in the country. We will work to continue building upon their excellent reputation while bringing additional value to company through our business network and relationships," said Miro Kesic, Managing Partner of Wildcat DX, LLC. Navis remains steadfast in its commitment to upholding the highest standards of corporate governance and transparency. The entire team is energized by this new chapter and the opportunities it brings for growth and continued success. For additional information, please contact: Craig Waters, CFO [email protected] (440)652-8748 SOURCE Wildcat DX, LLC